SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is seeing heightened trading activity and volatility as the community debates the implications of the FDA's second rejection of its melanoma drug, RP1. Investors are actively discussing the company's future following executive leadership changes at the FDA, with polarized opinions on whether management can force a regulatory reversal or if the company faces a long-term liquidity and survival challenge.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

Boost Run Inc. is trending as investors react to its recent Nasdaq debut and a significant partnership with Dell, which is fueling high-volume momentum. The community is actively debating the company's long-term potential as an NVIDIA Exemplar Cloud provider versus concerns regarding its post-SPAC volatility and lean corporate structure.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys is attracting significant attention as investors track its progress in establishing a domestic, China-free supply chain for critical heavy rare earth elements essential for U.S. defense systems ahead of upcoming procurement mandates. The community is actively debating the company's long-term execution capabilities and institutional backing, with discussions centered on its specialized metallization infrastructure and the strategic importance of replacing foreign-sourced materials.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Donald Trumps stock is trending amid intense online debate over his recent diplomatic trip to China and allegations of insider trading related to his financial disclosures. Investors and community members are actively clashing over the company's long-term viability, with vocal critics pointing to disappointing deal outcomes and retail shareholders navigating extreme volatility.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is seeing intense volatility and retail-driven speculation centered on its role as a key supplier of indium phosphide substrates for AI-focused data center infrastructure. While proponents highlight a long-term supply bottleneck and structural industry demand, critics are heavily debating the sustainability of the stock's massive valuation relative to its current financials and active insider selling, leading to a polarized market environment.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token ($VVV) is attracting significant investor attention as a key player in the decentralized AI sector, with community sentiment fueled by active token burns, strategic model integrations, and speculation surrounding potential exchange listings. Despite short-term price volatility and community debate over accumulation patterns, long-term holders remain focused on the token's utility in providing private, uncensored AI access.

iShares Trust - iShares China Large-Cap ETF

iShares China Large-Cap ETF

The iShares China Large-Cap ETF (FXI) is seeing increased attention as investors closely monitor ongoing trade negotiations between the U.S. and China, with sentiment driven by conflicting signals regarding potential tariff reductions and geopolitical tensions. Market participants are actively tracking diplomatic developments and economic indicators, with many focusing on whether these trade discussions will lead to a durable policy reset or continue to cause volatility in Chinese large-cap equities.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is currently in the spotlight as investors analyze its role as a defensive retail stalwart amidst rising inflation and complex consumer spending data. The community is actively debating the stock's elevated valuation and recent insider activity against its reputation as a safe-haven asset, all while keeping a close watch on consumer health signals ahead of upcoming earnings.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

KWEB is experiencing heightened market sensitivity and volatility as traders digest conflicting signals regarding US-China trade relations and upcoming high-level summits. While some investors are aggressively building long-term positions or rotating into China tech on valuation plays, others remain skeptical, citing continued regulatory uncertainty and persistent underperformance compared to domestic benchmarks.

Evolution Metals & Technologies Corp. engages in developing a global supply chain for critical minerals and materials. It focuses on automotive, renewable energy, and military and defense sectors. The company is headquartered in West Palm Beach, FL.

Evolution Metals & Technologies Corp.

Evolution Metals & Technologies Corp. Common Stock

Evolution Metals & Technologies Corp. (EMAT) is gaining significant investor attention due to its strategic focus on domestic rare earth magnet production and supply chain independence. The community is actively discussing the stock's potential for a short-squeeze driven by its extremely low float, while weighing the company's tech integration against concerns over its post-merger volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Innoviva (INVA) Tops Q1 Earnings Estimates

Innoviva (INVA) delivered earnings and revenue surprises of +3.53% and -1.83%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress

Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as...

Pfizer (PFE) Q1 Earnings and Revenues Top Estimates

Pfizer (PFE) delivered earnings and revenue surprises of +5.63% and +4.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Jennison Associates LLC Buys New Shares in Innoviva, Inc. $INVA

Jennison Associates LLC purchased a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 46,403 shares of the biotechnology company's stoc...

Merck (MRK) Reports Q1 Loss, Tops Revenue Estimates

Merck (MRK) delivered earnings and revenue surprises of +15.47% and +2.44%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Innoviva (INVA) to Release Quarterly Earnings on Wednesday

Innoviva (NASDAQ:INVA) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...

Innoviva, Inc. (NASDAQ:INVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Innoviva, Inc. (NASDAQ:INVA - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven brokerages that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and fiv...

Innoviva (NASDAQ:INVA) Shares Cross Above 200-Day Moving Average   - Time to Sell?

Innoviva (NASDAQ:INVA) Shares Cross Above 200-Day Moving Average - Here's Why...

Innoviva (NASDAQ:INVA) Shares Cross Above 200 Day Moving Average - Here's What Happened

Innoviva (NASDAQ:INVA) Share Price Crosses Above 200 Day Moving Average - Time to Sell...

Oliver Luxxe Assets LLC Makes New $1.69 Million Investment in Innoviva, Inc. $INVA

Oliver Luxxe Assets LLC acquired a new stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 84,671 shares of the biotechnology company's...

Innoviva, Inc. engages in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.42	--	--	N/A
Q1 '26	$0.39	$2.22	469.23%	BEAT
Q4 '25	$0.55	$1.94	252.11%	BEAT
Q3 '25	$0.46	$1.08	134.78%	BEAT
Q2 '25	$0.50	$0.77	54.30%	BEAT

INVA
Innoviva Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest INVA News

INVAInnoviva Inc